Floatz logo

Metformin

Cannabis Dependence

Nova Scotia Health AuthoritySmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Cannabis Dependence cohort.

Asset / SponsorPhaseRating
Clozapine
Dartmouth-Hitchcock Medical Center
Phase 4BB
Quetiapine
University of Cincinnati
Phase 4BB
Topiramate
University of Cincinnati
Phase 4BB
Risperidone
Dartmouth-Hitchcock Medical Center
Phase 4BB
Tirzepatide
McMaster University
Phase 3B

View all 13 →

Same molecule, other indications

Metformin is also rated in:

prediabetes syndromeActive
A
Indicative · Phase 4
81 / 100
View asset →
gestational diabetesDormant
A
Indicative · Phase 4
81 / 100
View asset →
diabetes mellitusActive
A
Indicative · Phase 4
80 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →